We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




False-Positive Mammogram Findings Tied to Apprehension, Willingness for Future Screening

By HospiMedica International staff writers
Posted on 27 Apr 2014
New research has shown that mammograms with false-positive findings were linked with increased short-term anxiety for women, and more women with false-positive results reported that they were more apt to undergo future breast cancer screening.

A percentage of women who undergo routine mammogram screening will experience false-positive findings that necessitate further evaluation to rule out breast cancer.

The authors, Anna N.A. More...
Tosteson, ScD, from the Dartmouth Institute for Health Policy and Clinical Practice (Lebanon, NH, USA), and colleagues reported quality-of-life (QoL) results from the Digital Mammographic Imaging Screening Trial (DMIST). The telephone survey was performed shortly after screening at 22 sites and 1,226 randomly selected women with positive and negative mammogram results were enrolled. Follow-up interviews were obtained from 1,028 of the women (534 with negative results, 494 with false-positive results).

Among women with a false-positive mammogram, 50.6% reported anxiety as moderate or higher and as extreme by 4.6%. However, that did not affect plans by women to undergo screening within the next two years. More women with false-positive results (25.7%) compared with women with negative findings (14.2%) reported that they were “more likely” to undergo future breast cancer screening.

“Our finding of time-limited harm after false-positive screening mammograms is relevant for clinicians who counsel women on mammographic screening and for screening guideline development groups,” the researchers noted.

Related Links:

Dartmouth Institute for Health Policy and Clinical Practice
Digital Mammographic Imaging Screening Trial



New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Hypodermic Syringe
SurTract™ Safety Syringe
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter to be CE marked for ventricular ablation (Photo courtesy of Medtronic)

Dual-Energy Mapping and Ablation Catheter Receives CE Mark for Ventricular Arrhythmias

Ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes, can be life-threatening and often occur in patients with advanced heart disease. Although catheter ablation... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.